Japan Lifeline Co., Ltd. (7575.T)

1,161.00 +18.00 (+1.57%) At close: 03:15PM JST

Japan Lifeline Co., Ltd.

Tennoz Ocean Square
25th Floor 2-2-20, Higashishinagawa Shinagawa-ku
Tokyo 140-0002
Japan
81 3 6711 5200
https://www.japanlifeline.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 1,166

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Keisuke Suzuki	President, CEO & Representative Director	N/A	N/A	1953
Mr. Atsuhiro Suzuki	Senior Executive Vice President & COO	N/A	N/A	1958
Mr. Kenji Yamada	Senior VP, Executive Manager of Corporate Administration Headquarters & Director	N/A	N/A	1971
Ms. Yumiko Hoshiba	VP, GM of Human Resources & General Affairs Department and Director	N/A	N/A	1962
Mr. Takayuki Kuronuma	Consultant	N/A	N/A	1956
Mr. Toru Takamiya	VP, Executive Manager of R&D and Manufacturing Headquarters & Director	N/A	N/A	1964
Mr. Tadashi Idei	VP, Exec. Manager of Regulatory Affairs HQ, GM of Safety Info Mgmt Div & Director	N/A	N/A	1965
Mr. Tatsuya Murase	SVP, Executive Manager of General Business Headquarters & CVG Business Unit and Director	N/A	N/A	1973
Shigeki Kitayama	Operating Officer & Senior Manager of EP Department of Arrhythmia Business Unit	N/A	N/A	N/A
Naohiro Nakada	Operating Officer, Asso Sr. Manager of EP Dpt of Arrhythmia Bus Unit, GM of EP Sales Promotion Div	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in JPY.

Description

Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. The company's cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts, as well as embolic coil deploying systems; and coronary and peripheral intervention products include PTCA and PTA guide wires, and PTCA balloon catheters. In addition, the company offers gastrointestinal intervention products that cholangioscope, biliary tube stent, papillary balloon dilatation catheter, self-expandable duodenal and colonic stent, endoscopic guidewire, and radiofrequency ablation systems; structural heart disease intervention products, such as radiofrequency wires and atrial septal defect closure devices; and neurovascular intervention products. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.

Corporate governance

Japan Lifeline Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.